financetom
Business
financetom
/
Business
/
Kelly Services Insider Sold Shares Worth $481,312, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kelly Services Insider Sold Shares Worth $481,312, According to a Recent SEC Filing
Mar 11, 2024 7:34 AM

10:06 AM EDT, 03/11/2024 (MT Newswires) -- Olivier Thirot, Executive Vice President, on March 07, 2024, sold 20,000 shares in Kelly Services ( KELYA ) for $481,312. Following the Form 4 filing with the SEC, Thirot has control over a total of 174,793 shares of the company, with 174,793 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/55135/000112760224009290/xslF345X03/form4.xml

Price: 24.24, Change: -0.52, Percent Change: -2.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Walmart CEO Doug McMillon to retire, insider John Furner named top boss
Walmart CEO Doug McMillon to retire, insider John Furner named top boss
Nov 14, 2025
(Reuters) -Walmart ( WMT ) said on Friday that CEO Doug McMillon would retire next year and that insider John Furner would succeed him as the retailer's top boss. Shares of the company fell about 3% in premarket trading. The move is the latest in a string of leadership changes sweeping through the retail sector as companies tackle tariff pressures,...
Galectin Therapeutics Q3 loss narrows
Galectin Therapeutics Q3 loss narrows
Nov 14, 2025
Overview * Galectin Therapeutics ( GALT ) Q3 net loss narrows to $8.2 mln from $11.2 mln last year * Operating expenses for Q3 decrease due to NAVIGATE trial conclusion * Company has $11.5 mln cash and $10 mln credit line to fund operations through June 2026 Outlook * Galectin expects FDA feedback on NAVIGATE data by year-end * Company...
Cocrystal Pharma Q3 loss narrows
Cocrystal Pharma Q3 loss narrows
Nov 14, 2025
Overview * Cocrystal Pharma ( COCP ) Q3 net loss decreases to $2 mln from $4.9 mln yr/yr * Company received FDA clearance for CDI-988 Phase 1b norovirus study starting Q1 2026 * Company granted NIH SBIR award to advance influenza A/B replication inhibitor program Outlook * Company to start Phase 1b norovirus study in Q1 2026 * Company received...
Walmart CEO Doug McMillon to retire, names insider John Furner as new CEO
Walmart CEO Doug McMillon to retire, names insider John Furner as new CEO
Nov 14, 2025
Nov 14 (Reuters) - Walmart ( WMT ) said on Friday that its chief executive officer Doug McMillon will retire next year, and will be replaced by insider John Furner as the new top boss. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved